These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31570212)

  • 1. [Reimbursement differences in the ambulatory specialized care (ASV) compared to the previous care system. An exemplary analysis in medical oncology treating gastrointestinal malignancies].
    Dengler R; Swiatek E; Pluntke S; Kaiser F; Schmitz S
    Z Evid Fortbild Qual Gesundhwes; 2019 Oct; 146():28-34. PubMed ID: 31570212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Outpatient medical specialist care (ASV): A multiperspective study on status quo, challenges and perspectives].
    Dengler R; Straub N; Bredow L; Becker J; Hornschuch M; Riedel O; Haug U; Waldeyer K; Hermes-Moll K; Osburg S; Martin J; Walawgo T; Heidt V; Froschauer S
    Z Evid Fortbild Qual Gesundhwes; 2022 Nov; 174():70-81. PubMed ID: 36097002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic Impact of the Introduction of Outpatient Medical Specialist Care (ASV) of Gastrointestinal Cancer Patients from a German Hospital Management Perspective.
    Jakobs F; Drost RMWA; Kron A; Heinen J; Hallek M; Reinhardt HC; Zander T; Kron F
    Oncol Res Treat; 2020; 43(10):498-505. PubMed ID: 32957103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [For discussion: Restructuring of medical specialist treatment using the example of ambulatory special medical care (ASV): Taking a critical look at its aims and implementation].
    Dengler R; Cassens M
    Z Evid Fortbild Qual Gesundhwes; 2018 May; 133():51-57. PubMed ID: 29678531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of costs and profits of ambulatory care of Marfan patients after initiation of a novel German legal directive (116 b SGB V)].
    Manow ML; Paulsen N; Rybczynski M; Mir T; Bernhardt AM; Treede H; Ohm G; Fuisting B; Rehder U; Meier F; Vogler M; Meinertz T; Overlack K; von Kodolitsch Y
    Med Klin (Munich); 2010 Aug; 105(8):529-37. PubMed ID: 20824410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Trans-Sectoral Patient Care in Pediatric Oncology: Quality Assurance by Novel Reimbursement Models for Outpatient Services].
    Reinke E; Jürgens H; Haier J; Froehlich B; Kontny U; Rossig C
    Klin Padiatr; 2020 Nov; 232(6):289-293. PubMed ID: 32365390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Readiness to Participate in Ambulatory Special Medical Care (ASV): A Critical Appraisal - Results of a Survey Amongst Office-Based Oncologists in Germany].
    Dengler R; Walawgo T; Baumann W; Cassens M
    Gesundheitswesen; 2019 Jun; 81(6):478-485. PubMed ID: 29212094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The growing endangerment of specialists in private practice--opening up access to hospital outpatient clinics from a legal point of view].
    Luxenburger B
    Z Arztl Fortbild Qualitatssich; 2006; 100(1):69-73. PubMed ID: 16524234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Outpatient specialist medical treatment (ASV)-a new treatment level in rheumatology].
    Edelmann E; Lakomek HJ; Bessler F; Braun J; Froschauer S; Hellmich B; von Hinüber U; Kalthoff L; Karberg K; Kekow J; Krause A; Müller-Brodmann W; Munte A; Ruehlmann JM; Zinke S
    Z Rheumatol; 2019 Oct; 78(8):765-773. PubMed ID: 31456005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostics and Eradication Therapy for MRSA Carriers in the Outpatient Sector: an Analysis of the Reimbursement Situation in the Light of Current Reimbursement Changes].
    Schwendler M; Hübner CS; Fleßa S
    Gesundheitswesen; 2017 Oct; 79(10):855-862. PubMed ID: 27300096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons learned from the reimbursement profile of a mature private medical toxicology practice: office-based practice pays.
    Thompson TM; Leikin JB
    J Med Toxicol; 2015 Mar; 11(1):59-64. PubMed ID: 25502603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rehabilitation in geriatric patients after ischemic stroke--a comparison of 2 organisational systems in Germany using claims data of a statutory health insurance fund].
    Abbas S; Ihle P; Hein R; Schubert I
    Rehabilitation (Stuttg); 2013 Dec; 52(6):375-82. PubMed ID: 23824567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [From pay-for-effort to pay-for-performance--an analysis of the Swiss health care system with focus on the inpatient sector].
    Rieger UM; Prengel A; Burla S; Rüdiger M; Pierer G; Heberer M
    Praxis (Bern 1994); 2009 Dec; 98(25):1499-509. PubMed ID: 20013686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hospital (public and private) and ambulatory care systems: structures and principles of charges].
    Rusch E
    Rev Prat; 2001 Apr; 51(7):797-804. PubMed ID: 11387679
    [No Abstract]   [Full Text] [Related]  

  • 15. [Medical care unit -- a suitable instrument for ambulatory patient-adequate care and performance-related remuneration].
    Rudolph P; Isensee D; Gerlach E; Gross H
    Zentralbl Chir; 2013 Feb; 138(1):45-52. PubMed ID: 22403014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medical care and costs in the last year of life - propensity score matching of AAPV and SAPV insurants].
    Rusche H; Kreimendahl F; Huenges B; Becka D; Rychlik R
    Dtsch Med Wochenschr; 2016 Oct; 141(22):e203-e212. PubMed ID: 27824408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. German remuneration system for out-patient medical services.
    Hauswaldt E; Hauswaldt J
    Eur J Gen Pract; 2005 Mar; 11(1):37-8. PubMed ID: 15841067
    [No Abstract]   [Full Text] [Related]  

  • 18. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
    Führlinger S
    Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quality of ambulatory medical care in the context of age and care-dependency: Results of a cross-sectional analysis of German health claims data].
    Seibert K; Stiefler S; Domhoff D; Wolf-Ostermann K; Peschke D
    Z Evid Fortbild Qual Gesundhwes; 2020 Sep; 155():17-28. PubMed ID: 32811774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pricing and reimbursement of pharmaceuticals in Belgium.
    Annemans L; Crott R; De Clercq H; Huybrechts M; Peys F; Robays H; Steens I; Vanschoubroek K; Winderickx P
    Pharmacoeconomics; 1997 Mar; 11(3):203-9. PubMed ID: 10165309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.